New treatment for rare blood cancer approved for NHS use in England
The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin to treat some adults with a rare type of fast-growing lymphoma. Clinical trial data suggests that combining the targeted treatment with chemotherapy could give people with systemic anaplastic large cell lymphoma more time before their disease progresses and help them […]
Continue Reading